Postpartum Glucose Testing Rates Following Gestational Diabetes Mellitus and Factors Affecting Testing Non-compliance from Four Tertiary Centers in Korea.
10.3346/jkms.2015.30.12.1841
- Author:
Geum Joon CHO
1
;
Jung Joo AN
;
Suk Joo CHOI
;
Soo Young OH
;
Han Sung KWON
;
Soon Cheol HONG
;
Ja Young KWON
Author Information
1. Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea.
- Publication Type:Multicenter Study ; Original Article
- Keywords:
Diabetes, Gestational;
Postpartum Glucose Screening;
Referral
- MeSH:
Blood Glucose/*metabolism;
Diabetes, Gestational/*blood;
Fasting;
Female;
*Glucose Tolerance Test;
Hemoglobin A, Glycosylated/metabolism;
Humans;
Mass Screening/statistics & numerical data;
Patient Compliance/statistics & numerical data;
Postpartum Period/*blood;
Pregnancy;
Republic of Korea;
Retrospective Studies;
Tertiary Care Centers
- From:Journal of Korean Medical Science
2015;30(12):1841-1846
- CountryRepublic of Korea
- Language:English
-
Abstract:
The purpose of this study was to investigate postpartum glucose testing rates in patients with gestational diabetes mellitus (GDM) and to determine factors affecting testing non-compliance in the Korean population. This was a retrospective study of 1,686 patients with GDM from 4 tertiary centers in Korea and data were obtained from medical records. Postpartum glucose testing was conducted using a 2-hr 75-g oral glucose tolerance, fasting glucose, or hemoglobin A1C test. Test results were categorized as normal, prediabetic, and diabetic. The postpartum glucose testing rate was 44.9% (757/1,686 patients); and of 757 patients, 44.1% and 18.4% had pre-diabetes and diabetes, respectively. According to the multivariate analysis, patients with a high parity, larger weight gain during pregnancy, and referral from private clinics due to reasons other than GDM treatment were less likely to receive postpartum glucose testing. However, patients who had pharmacotherapy for GDM were more likely to be screened. In this study, 55.1% of patients with GDM failed to complete postpartum glucose testing. Considering the high prevalence of diabetes (18.4%) at postpartum, clinicians should emphasize the importance of postpartum diabetes screening to patients with factors affecting testing noncompliance.
